Combined use of pathological and genomic alteration analyses for the diagnosis of gray zone lymphoma.
Nishimura K, Miyazaki K, Suzuki K, Hachiya K, Tono Y, Tamaru S, Imai H, Miyoshi H, Ohshima K, Okugawa Y, Tawara I, Yamaguchi M.
Nishimura K, et al. Among authors: imai h.
J Clin Exp Hematop. 2022;62(4):253-257. doi: 10.3960/jslrt.22024.
J Clin Exp Hematop. 2022.
PMID: 36575002
Free PMC article.